Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

Author：                

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|4|1707-1714

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.4, 2015-01, pp. : 1707-1714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy

By Shi Yan  

Tumor Biology, Vol. 32, Iss. 2, 2011-04 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

By Bertucci François  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1 146 patients with early breast cancer

By Arriagada Rodrigo   Spielmann Marc   Koscielny Serge   Le Chevalier Thierry   Delozier Thierry   Rémé-Saumon Monique   Ducourtieux Muriel   Tursz Thomas   Hill Catherine  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 458-466

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracyclinebased neoadjuvant chemotherapy

By              

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 614-620

Spandidos Publications

Access to resources Recommend Favorite

The expression and clinical significance of PI3K, pAkt and VEGF in colon cancer

By          

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 763-766

Spandidos Publications

Access to resources Recommend Favorite